13F History

Essex Woodlands Management, Inc.

Holdings History for Revance Therapeutics, Inc. - COM (RVNC)

Symbol: RVNC on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024	0.68%		$2.37M	457K			$5.19	Q3 2024
6/30/2024	0.38%		$1.17M	457K			$2.57	Q2 2024
3/31/2024	0.65%		$2.25M	457K			$4.92	Q1 2024
12/31/2023	0.99%		$4.02M	457K			$8.79	Q4 2023
9/30/2023	4.62%		$5.24M	457K			$11.47	Q3 2023
6/30/2023	8.76%		$11.6M	457K			$25.31	Q2 2023
3/31/2023	8.52%		$14.7M	457K			$32.21	Q1 2023
12/31/2022	4.7%		$8.44M	457K			$18.46	Q4 2022
9/30/2022	5.26%		$12.3M	457K			$27.00	Q3 2022
6/30/2022	2.69%		$6.32M	457K			$13.82	Q2 2022
3/31/2022	2.28%		$8.91M	457K			$19.50	Q1 2022
12/31/2021	1.79%	-0.06%	$7.46M	457K	-15,505	-3.28%	$16.32	Q4 2021
9/30/2021	2.92%	-5.32%	$13.2M	473K	-861,102	-64.6%	$27.86	Q3 2021
6/30/2021	5.51%	-5.89%	$37.3M	1.33M	-1,426,258	-51.7%	$27.95	Q2 2021
3/31/2021	12.1%	-2.54%	$77.1M	2.76M	-582,097	-17.4%	$27.95	Q1 2021
12/31/2020	24.6%		$94.7M	3.34M			$28.34	Q4 2020
9/30/2020	44.6%		$84M	3.34M			$25.14	Q3 2020
6/30/2020	40%		$81.6M	3.34M			$24.42	Q2 2020
3/31/2020	31.8%		$49.5M	3.34M			$14.80	Q1 2020
12/31/2019	25.4%		$54.2M	3.34M			$16.23	Q4 2019
9/30/2019	27.2%		$43.4M	3.34M			$13.00	Q3 2019
6/30/2019	25.2%		$43.3M	3.34M			$12.97	Q2 2019
3/31/2019	26.7%		$52.7M	3.34M			$15.76	Q1 2019
12/31/2018			$91.7M	3.34M			$27.45^*	Q4 2018
9/30/2018	17.5%		$83.1M	3.34M			$24.85	Q3 2018
6/30/2018	22%	-3.29%	$91.7M	3.34M	-500,000	-13%	$27.45	Q2 2018
3/31/2018	26.6%		$118M	3.84M			$30.80	Q1 2018
12/31/2017	25.4%	-4.96%	$137M	3.84M	-750,000	-16.3%	$35.75	Q4 2017
9/30/2017	22.9%		$127M	4.59M			$27.55	Q3 2017
6/30/2017	22.4%		$121M	4.59M			$26.40	Q2 2017
3/31/2017	22.5%		$95.5M	4.59M			$20.80	Q1 2017
12/31/2016	22.5%		$95.1M	4.59M			$20.70	Q4 2016
9/30/2016	16.3%		$74.4M	4.59M			$16.21	Q3 2016
6/30/2016	16.7%		$62.5M	4.59M			$13.60	Q2 2016
3/31/2016	21.9%		$80.2M	4.59M			$17.46	Q1 2016
12/31/2015	29.7%		$157M	4.59M			$34.16	Q4 2015
9/30/2015	26%		$137M	4.59M			$29.76	Q3 2015
6/30/2015	27.8%		$147M	4.59M			$31.98	Q2 2015
3/31/2015	19.9%		$95.2M	4.59M			$20.73	Q1 2015
12/31/2014	24.3%		$77.8M	4.59M			$16.94	Q4 2014
9/30/2014	32.3%		$88.8M	4.59M			$19.33	Q3 2014
6/30/2014	37.1%		$156M	4.59M			$34.00	Q2 2014
3/31/2014	42.4%	+42.4%	$145M	4.59M	+4,592,047	NEW	$31.50	Q1 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.